Latest Leverage News

Page 54 of 770
Aland Equity Group (ASX: AEG) reveals advanced talks on a property funds management transaction linked to its chairman, explaining recent unusual share price activity.
Claire Turing
Claire Turing
7 May 2026
Unith Ltd (ASX:UNT) posted Q3 FY2026 revenue of A$1.26 million, secured a $2 million finance facility to fuel commercial expansion, and showcased significant advancements in its AI Digital Humans platform, including proprietary streaming technology and SDK launches.
Sophie Babbage
Sophie Babbage
7 May 2026
Diablo Resources has secured an 80% interest in the historic Horn Silver Project in Utah, a prolific high-grade silver and gold mine, supported by a $3.5 million placement to fund immediate drilling and district-scale exploration.
Maxwell Dee
Maxwell Dee
7 May 2026
Neuren Pharmaceuticals saw a 20% jump in Q1 2026 DAYBUE net sales to US$101 million, with royalties up 23%. The Japan trofinetide trial has been fast-tracked, and the new powder formulation DAYBUE STIX gains early traction.
Victor Sage
Victor Sage
7 May 2026
GreenTech Metals has confirmed thicker, high-grade PGE-Cu-Ni mineralisation at its Munni Munni Project through Phase 1 drilling and historic core resampling, setting the stage for a JORC 2012 resource update.
Maxwell Dee
Maxwell Dee
7 May 2026
Tali Resources has raised $3 million through a discounted share placement to bankroll a multi-phase drilling campaign at its West Arunta Project, aiming to capitalise on recent geophysical advances.
Maxwell Dee
Maxwell Dee
7 May 2026
InteliCare has secured A$2.05 million through a placement to back its commercial expansion following major aged care contracts and initial retirement village deployments.
Sophie Babbage
Sophie Babbage
7 May 2026
Xenitra Limited has secured $1.25 million through a share placement to accelerate its OTC medicines rollout and expand its OPAL RWA token ecosystem, with shareholder approval pending for attached options.
Ada Torres
Ada Torres
7 May 2026
Green360 Technologies has successfully demonstrated its Eco-Clay product as a 50% Portland cement replacement in shotcrete applications, opening new avenues in underground and civil infrastructure markets.
Victor Sage
Victor Sage
7 May 2026
PYC Therapeutics has dosed the first patient in its Phase 1b trial of PYC-003, targeting Polycystic Kidney Disease, aiming to establish safety and efficacy markers ahead of registrational studies.
Ada Torres
Ada Torres
7 May 2026
Superloop showcased sustained earnings improvement and strategic fibre network expansion, spotlighting its pending Lightning Broadband acquisition to boost FTTP scale.
Sophie Babbage
Sophie Babbage
7 May 2026
NoviqTech (ASX: NVQ) advances its biochar carbon removal strategy with a key non-binding MoU covering 70% of credits from its Great Barrier Reef project, targeting 2026 commercial milestones.
Maxwell Dee
Maxwell Dee
7 May 2026